In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases
Coronary heart disease is a major cause of death and disability in developed countries. Stent implantation has become an efficacious treatment for a culprit lesion vessel of the coronary artery. However, 10%–20% restenosis is still an important complication that restricts the clinical safety and eff...
Saved in:
| Main Authors: | Dai-Min Zhang, Shaoliang Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2020/8104939 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-coated balloon in patients with in-stent restenosis: A prospective observational study
by: Shuvanan Ray, et al.
Published: (2025-03-01) -
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
by: Hui Wang, et al.
Published: (2024-12-01) -
Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01) -
Drug‐Coated Balloons in In‐Stent Restenosis, a New Standard of Care or Yesterday's News?
by: Nicholas Weight, et al.
Published: (2024-12-01) -
Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography
by: Toru Miyazaki, et al.
Published: (2019-01-01)